PMS · Equity · Small Cap
Molecule Ventures - Growth
Fund size₹648 Cr
Alpha (3Y)15.40%
3Y return30.88%
Fund age3 yrs 6 mo
Fund Manager
Growth of₹Cr
Molecule Ventures Growth
Returns: How it has done
| Scheme / Benchmark | YTD | 1Y | 2Y | 3Y | 5Y | Since inception |
|---|---|---|---|---|---|---|
| Molecule Ventures Growth | — | −3.53% | 30.09% | 30.88% | — | 30.55% |
| Nifty 500 | −8.38% | 9.73% | 20.98% | 14.17% | — | 15.05% |
| Excess over benchmark | — | −13.26% | 9.11% | 16.71% | — | 15.50% |
Returns up to one year are absolute; two years and above are annualised (CAGR). YTD is calendar-year-to-date. As on 31 Jan 2025.
Risk : What you take on to earn the return
Volatility
22.91%
Benchmark approx 13.42%
A standard deviation reflecting historical swings.
Sensitivity
1.01
Beta vs benchmark 1.00 · 1% more reactive
How strongly the scheme moves with the index.
Risk-reward
1.01
Sharpe
Excess return gained per unit of volatility.
Capture ratio
120 / 28
Upside / Downside Capture
Share of market gains captured versus losses absorbed.
Portfolio Details : Where the money actually sits
Avg market cap
₹3,050 Cr
Asset class
Equity
Market cap
Large cap
Mid cap
Small cap92.50%
Cash & others
Fees
VariablePlan A · Performance LinkedFixed Management FeeNone
Performance Fee20% of profit
Hurdle RateNot applicable
No exit load. Lock-in: Nil.
Let's start a
conversation
conversation
- Compare this PMS against 3,000+ others with our research desk
- Build a long-term portfolio around your goals, not a one-off buy
- Experts with decades of experience.
Private. Personal. No obligation.
We will only use these details to contact you about this enquiry. No spam.